DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.89.
DCGO has been the subject of several research reports. Needham & Company LLC lowered their target price on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a report on Friday, February 28th. Stifel Nicolaus lowered their price objective on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research note on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and cut their target price for the company from $5.00 to $2.85 in a research report on Friday, February 28th.
View Our Latest Stock Analysis on DCGO
DocGo Stock Performance
Hedge Funds Weigh In On DocGo
Several institutional investors and hedge funds have recently added to or reduced their stakes in DCGO. Centiva Capital LP purchased a new stake in shares of DocGo during the third quarter valued at about $43,000. Summit Investment Advisors Inc. raised its stake in shares of DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after acquiring an additional 2,968 shares in the last quarter. Prudential Financial Inc. purchased a new stake in DocGo during the fourth quarter valued at approximately $55,000. Intech Investment Management LLC acquired a new stake in DocGo in the third quarter valued at approximately $62,000. Finally, Royce & Associates LP purchased a new position in DocGo in the fourth quarter worth $64,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- ESG Stocks, What Investors Should Know
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Why Are These Companies Considered Blue Chips?
- Top 3 Beverage Stocks Pouring Out Profits
- How to Short a Stock in 5 Easy Steps
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.